Sanity Group develops cannabinoid-based pharmaceuticals and wellness products that utilize precise extraction methods to ensure consistent dosing and efficacy. The company addresses the need for reliable therapeutic options in the growing market for cannabinoid treatments.
Funding
$130.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The European market for cannabinoid-based therapies faces challenges due to varying regulations, healthcare systems, and a historical research backlog regarding the therapeutic potential of cannabis. This results in inconsistent access to reliable cannabinoid treatments and wellness products across different regions.
Solution
Sanity Group addresses these challenges by developing and distributing cannabinoid-based pharmaceuticals and wellness products tailored to the specific needs of the European market. The company focuses on research and development, utilizing precise extraction methods to ensure consistent dosing and efficacy. Through its Sanity Medical division, the company develops and distributes innovative cannabis pharmaceuticals, while Sanity Care focuses on superior consumer products based on non-psychoactive cannabinoids. Sanity Science conducts R&D and produces high-quality extracts for all operational business areas.
Target Audience
Sanity Group targets patients seeking cannabinoid-based therapies, healthcare professionals, and consumers interested in cannabinoid-based wellness products in the European market.
Features
- Development of cannabinoid-based pharmaceuticals adhering to GMP standards
- Distribution of medicinal cannabis products to pharmacies and clinical institutions through Vayamed
- Development of consumer CBD products through vaay
- R&D projects focused on exploring the therapeutic potential of cannabinoids
- High-quality cannabinoid extracts for pharmaceutical and consumer applications
- Medical and political advisory boards to inform strategic direction and address perception issues
- Partnerships with production facilities in Europe, South Africa, and Canada